The aim of this study was to elucidate the possible role of impaired egress as a determinant of lymphadenopathy in CLL, and relief of impaired egress as an explanation for the mobilizing effect of BCR signaling pathway inhibitors. Here, BCR is linked to B-cell chronic lymphocytic leukemia.